USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC

N/ANot Yet RecruitingNCT06852794

Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled

Overview

The present study aims to evaluate the usefulness of artificial intelligence (AI) in the back-office of an ILD (Interstitial Lung Disease) clinic.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

100

Conditions

Interstitial Disease

Interventions

SurveyOTHER

The patients will receive questionnaires. The enrolled patients will be asked to provide feedback on the answers they read.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Patients attending ILD clinic of the IRCCS Fondazione Policlinico A. Gemelli. Exclusion Criteria: * Patients unable or unwilling to sign the informed consent * Patients who are senders of one of the emails chosen for the questionnaire * Patients with manifest inability to fill out the questionnaire

Outcomes

Primary Outcomes

Variation of VAS scores of clarity of the message in questionnaires administered at T1 and at T2

Time frame: 15 days

Variation of VAS scores of empathy conveyed in questionnaires administered at T1 and at T2

Time frame: 15 days

Secondary Outcomes

Percentage of answers recognised correctly as answers provided by AI among the total of answers flagged as provided by AI by study subjects

Time frame: 1 day

Stratify the results by patients' demographic characteristics and past experiences with artificial intelligence systems.

Time frame: 1 day

Central Contacts

Luca Richeldi, MD

CONTACT

+390630157857 luca.richeldi@policlinicogemelli.it

Diana Verdirosi, Sc

CONTACT

+390630157724 diana.verdirosi@policlinicogemelli.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.